Jackson Thornton Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$384K Buy
15,962
+1,294
+9% +$33.8K 0.03% 207
2026
Q1
$395K Buy
14,668
+1,953
+15% +$52K 0.04% 137
2025
Q4
$323K Buy
12,715
+240
+2% +$6.05K 0.03% 179
2025
Q3
$320K Buy
12,475
+1,858
+18% +$45.9K 0.03% 172
2025
Q2
$272K Buy
+10,617
New +$248K 0.03% 95

Other funds holding PFE

Jackson Thornton Wealth Management's PFE Position: Q2 2026 in Review

Jackson Thornton Wealth Management increased its Pfizer (PFE) stake by 8.8% in Q2 2026, buying an estimated $33.8K and bringing the position to 15,962 shares worth $384K. The position accounts for 0.03% of the portfolio, ranked #207.

Jackson Thornton Wealth Management first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $395K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Jackson Thornton Wealth Management held 15,962 shares of Pfizer worth $384K as of Q2 2026.
  • Jackson Thornton Wealth Management bought 1,294 Pfizer shares in Q2 2026, an estimated $33.8K.
  • Pfizer made up 0.03% of Jackson Thornton Wealth Management's portfolio in Q2 2026, its #207 holding.
  • Jackson Thornton Wealth Management first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
  • Jackson Thornton Wealth Management's Pfizer position peaked at $395K in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Jackson Thornton Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.